DEPARTMENT OF HEALTH AND HUMAN SERVICES  
BUREAU OF EPIDEMIOLOGY  
DIVISION OF LIFECOURSE EPIDEMIOLOGY AND GENOMICS  
MANDATORY REPORTING OF CHRONIC DISEASES  
(By authority conferred on the director of the department of health and human services by  
sections 2221, 2226, 2233, and 5111 of the public health code, 1978 PA 368, MCL  
333.2221, 333.2226, 333.2233, 333.5111, and section 8 of the critical health problems  
reporting act, 1978 PA 312, MCL 325.78)  
R 330.131 Definitions.  
Rule 131. (1) As used in these rules:  
(a) “Chronic disease registry” means the database maintained by the department that  
contains patient-level health information about individuals with a diagnosed chronic  
disease, including, but not limited to, diagnostic and demographic information.  
(b) “Code” means the public health code, 1978 PA 368, MCL 333.1101 to 333. 25211.  
(c) "Department" means the department of health and human services.  
(d) “Director” means the director of the department.  
(e) "Health information" means information about an individual, whether oral or  
recorded in any form or medium that relates to the past, present, or future physical or  
mental health or condition of an individual, and the provision of health care to an  
individual. Health information includes aggregate information if, in the opinion of the  
department, it could potentially lead to reidentification of an individual.  
(f) “Health professional" means an individual licensed under article 15 of the code,  
MCL 333.16101 to 333.18838, to work as a physician, a physician's assistant, or a nurse  
practitioner.  
(g) "Local health department" means a health department established under the  
provisions of part 24 of the code, MCL 333.2401 to 333.2498.  
(h) "Public health investigation" means the collection of medical, epidemiologic,  
exposure, and other information to determine the cause of illness or disability, which is  
used to determine appropriate actions to prevent or mitigate additional illness or  
disability.  
(i) “Report” means documents or data containing health information provided to the  
department consistent with this ruleset.  
(2) A term defined in the code has the same meaning when used in these rules.  
History: 2024 MR 10, Eff. May 1, 2024.  
R 330.132 Reportable information.  
Rule 132. (1) Health professionals and health facilities must provide reports to the  
department in a format that ensures the inclusion of all patient information, if available  
and applicable, as follows:  
Page 1  
(a) Last and first name and middle initial.  
(b) Sex.  
(c) Race.  
(d) Ethnicity.  
(e) Birth date or age.  
(f) Current residential address.  
(g) Telephone number.  
(h) If the individual is a minor, the name of the individual’s parent or guardian.  
(i) Social security number.  
(j) The date of symptom onset, if applicable.  
(k) The date of diagnosis.  
(l) The diagnosis, including diagnostic code.  
(m) Prescribed medications, if they are available to the health professional or health  
facility, and the health professional or health facility is able to report them in the format  
prescribed by the department.  
(n) Brief narrative of the patient’s signs and symptoms, clinical findings, results of  
other diagnostic tests, and clinical outcome, if available to the health professional or  
health facility.  
(2) The reporting health professional shall provide the name, address, telephone, and  
other contact information, including, but not limited to, email communication, for the  
ordering physician or physicians as directed by the department.  
(3) The reporting health facility shall provide the facility’s name, address, telephone,  
and other contact information, including, but not limited to, email communication, as  
directed by the department.  
(4) Submitted reports must meet data quality, format, and timeliness standards  
prescribed by the department.  
History: 2024 MR 10, Eff. May 1, 2024.  
R 330.133 Reporting responsibilities.  
Rule 133. (1) Health professionals and health facilities capable of reporting to the  
department via an electronic health record must do so on a real-time, ongoing basis.  
(2) Health professionals and health facilities that do not submit reports consistent with  
subrule (1) of this rule shall provide reports to the department as follows:  
(a) Reports must be made within 3 months following a request by the department or  
local health department.  
(b) The department shall notify health professionals and health facilities when reports  
of a chronic disease must be submitted.  
(3) Nothing in this rule should be construed to relieve a health professional or health  
facility from reporting to any other entity as required by state, federal, or local statutes or  
regulations or in accordance with accepted standard of practice, except that reporting in  
compliance with this rule satisfies the reporting requirements of section 5111 of the code  
, MCL 333.5111.  
History: 2024 MR 10, Eff. May 1, 2024.  
Page 2  
R 330.134 Chronic disease registry advisory board.  
Rule 134. (1) The department shall create a chronic disease registry advisory board that  
convenes at the time and place instructed by the director and considers proposals and  
requests for the addition or removal of new reportable chronic diseases.  
(2) The chronic disease registry advisory board shall consist of not less than 12  
members appointed by the director as follows:  
(a) One individual representing the Michigan Health and Hospital Association.  
(b) Two individuals representing the department’s public health administration.  
(c) One individual representing a chronic disease organization.  
(d) One individual representing a local health department.  
(e) One individual representing the Michigan State Medical Society.  
(f) One individual representing emergency medical services.  
(g) One individual representing the chronic disease academic community.  
(h) One individual representing a minority-serving community-based organization.  
(i) One individual representing a tribal health agency.  
(j) One individual representing a health system or hospital in this state.  
(k) One individual representing the general public.  
(3) In addition to those representatives named in subrule (2), the director may appoint  
additional representatives to the board.  
(4) As directed by the department, members of the board shall maintain and adhere to  
the chronic disease registry advisory board’s bylaws, including member term limits,  
member nominations, subcommittee formation, and other policies and procedures  
relevant to the board’s ongoing operations.  
(5) The board shall examine the public health need for the collection of this information  
and may request assistance from the department to inform their recommendation  
regarding the addition or removal of a chronic disease as needed. This information may  
include requesting supplementary information from the individual or party proposing the  
chronic disease, convening subject-matter experts or individuals with knowledge of the  
particular condition, or assembling ad-hoc subcommittees.  
(6) The board shall release its recommendations, including whether a chronic disease  
should be made reportable, to the director of the department. The board may review or  
modify their recommendation at any time prior to the director’s review. The director shall  
then approve, modify, or reject the recommendations of the board.  
History: 2024 MR 10, Eff. May 1, 2024.  
R 330.135 Investigation and quality assurance.  
Rule 135. (1) The department, upon receiving a report under R 330.133, may request  
more information from the reporting entity. The reporting entity must provide the  
information to the department no later than 30 days after the request is made.  
(2) The department shall consult with local health departments in the development of  
procedures for processing chronic disease reports and conducting follow-up  
investigations to ensure efficient, non-duplicative, and effective public health response.  
(3) Requests by the department or local health departments for individual medical and  
epidemiologic information to validate the completeness and accuracy of reporting are  
Page 3  
specifically authorized. Persons or organizations that receive such requests must provide  
the information sought to the requesting organization promptly and no later than 30 days  
after the request is made.  
(4) Health information from reported chronic disease cases shall be stored in a  
reasonably secure manner by the department.  
History: 2024 MR 10, Eff. May 1, 2024.  
R 330.136 Confidentiality of reports.  
Rule 136. (1) To the maximum extent permitted by law, reports and health information  
collected under these rules are not public records and are exempt from disclosure under  
the freedom of information act, 1976 PA 442, MCL 15.231 to 15.246.  
(2) Reports and health information collected under this rule are medical records for the  
purpose of section 13(1)(l) of the freedom of information act, 1976 PA 442, MCL 15.243.  
(3) Except as provided in subrule (5) of this rule, health information that is gathered in  
connection with an investigation is confidential and is not open to public inspection. All  
persons in possession of reports and health information collected under these rules shall  
maintain the confidentiality of reports and health information and shall not reveal the  
identity of any person.  
(4) Records released to a legislative body must not contain information that identifies or  
could reasonably be expected to identify a specific individual.  
(5) Information collected under these rules must be used for epidemiologic  
investigation and evaluation. The department and local health departments may release  
reports or information under any of the following conditions:  
(a) The department receives written consent from the individual or consent from a  
minor’s parent or legal guardian after requesting the release of information.  
(b) As necessary for the department to carry out its duties designated by the code.  
(c) If necessary for the purpose of research designed to contribute to generalizable  
knowledge, with documented approval by the department’s institutional review board.  
History: 2024 MR 10, Eff. May 1, 2024.  
Page 4  
;